Subtenon Autologous Platelet-Rich Plasma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Subtenon Autologous Platelet-Rich Plasma, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases [Phase 1, Phase 2]